Dr. Andrew Venteicher specializes in minimally invasive, endoscopic endonasal, and traditional open microsurgical approaches to cranial base tumors and cerebrovascular diseases. He is the neurosurgical director of the Center for Cranial Base Surgery, which focuses on diagnosis and comprehensive treatment for patients with tumors along the base of the brain, pituitary gland, and brainstem.
Dr. Venteicher earned his BA from the University of Pennsylvania in Mathematics, Biochemistry and Economics, as well as an MS in Chemistry. He attended Stanford for both his MD and PhD in Biophysics, trained at Harvard Medical School for his residency, and was selected for the prestigious cerebrovascular and cranial base fellowship at the University of Pittsburgh.
On the research side, Dr. Venteicher is part of a new translational research initiative between the U's Medical School and the Masonic Cancer Center that is exploring the genomics of brain tumors. His laboratory focuses on using new molecular techniques to understand how and why brain tumors develop and resist chemotherapy and radiation treatment. Translational research efforts such as these are of particular importance to identify new treatment options for patients with these diseases. He was one of the first to move into the new multidisciplinary consortium located at the Masonic Cancer Center Discovery Labs in the Malcolm Moos Health Sciences Tower on campus.